Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol

被引：0
|
作者：
Qiang-ling Sun
Hui-fang Sha
Xiao-hua Yang
Guo-liang Bao
Jing Lu
Yin-yin Xie
机构：
[1] Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University,Basic Research Laboratory
[2] Ruijin Hospital of Shanghai Jiaotong University,Institute of Hematology
来源：
Journal of Cancer Research and Clinical Oncology | 2011年 / 137卷
关键词：
Chemoresistance; Non-Small Cell Lung Cancer (NSCLC); Paclitaxel; Two-dimensional difference gel electrophoresis (2D-DIGE);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：521 / 532
页数：11
相关论文
共 50 条
  • [21] EVIDENCE FOR THROMBOXANE BIOSYNTHESIS IN A HUMAN-LUNG ADENOCARCINOMA CELL-LINE, A549
    HUBBARD, WC
    ALLEY, MC
    MCLEMORE, TL
    BOYD, MR
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 692 - 692
  • [22] Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549
    Ye, Bin
    Xie, Yan
    Qin, Zheng-hong
    Wu, Jun-chao
    Han, Rong
    He, Jing-kang
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (11) : 1397 - 1401
  • [23] Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549
    Bin Ye
    Yan Xie
    Zheng-hong Qin
    Jun-chao Wu
    Rong Han
    Jing-kang He
    Acta Pharmacologica Sinica, 2011, 32 : 1397 - 1401
  • [24] Sp1 Upregulates Survivin Expression in Adenocarcinoma of Lung Cell Line A549
    Chen, Yuqing
    Wang, Xiaojing
    Li, Wei
    Zhang, Hailong
    Zhao, Chengling
    Li, Yan
    Wang, Zhenhuan
    Chen, Changjie
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2011, 294 (05): : 774 - 780
  • [25] Antisense oligodeoxynucleotides against thrombomodulin suppress the cell growth of lung adenocarcinoma cell line A549
    Fujiwara, M
    Jin, EJ
    Ghazizadeh, M
    Kawanami, O
    PATHOLOGY INTERNATIONAL, 2002, 52 (03) : 204 - 213
  • [26] Curcumin induced autophagy anticancer effects on human lung adenocarcinoma cell line A549
    Liu, Furong
    Gao, Song
    Yang, Yuxuan
    Zhao, Xiaodan
    Fan, Yameng
    Ma, Wenxia
    Yang, Danrong
    Yang, Aimin
    Yu, Yan
    ONCOLOGY LETTERS, 2017, 14 (03) : 2775 - 2782
  • [27] KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cells
    Pu, Junyi
    Shen, Jianfeng
    Zhong, Zihua
    Yanling, Ma
    Gao, Jie
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) : 639 - 647
  • [28] Proapoptotic lipid nanovesicles: Synergism with paclitaxel in human lung adenocarcinoma A549 cells
    Joshi, Nitin
    Shanmugam, Thanigaivel
    Kaviratna, Anubhav
    Banerjee, Rinti
    JOURNAL OF CONTROLLED RELEASE, 2011, 156 (03) : 413 - 420
  • [29] Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro
    Chen, Xiang-Qi
    Wang, Yu-Lan
    Li, Zhi-Ying
    Lin, Ting-Yan
    MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 347 - 352
  • [30] RESISTANT MECHANISMS OF CISPLATIN IN HUMAN LUNG ADENOCARCINOMA CELL LINE A549DDP
    詹茂程
    刘叙仪
    蔡鹏
    徐光炜
    ChineseJournalofCancerResearch, 1997, (03) : 24 - 28
12345